中医杂志(英文版)2024,Vol.44Issue(1) :145-155.DOI:10.19852/j.cnki.jtcm.20231110.006

Efficacy of Tounongsan decoction(透脓散方)on pyogenic liver abscess:network pharmacology and clinical trial validation

ZHANG Qi CHEN Dexuan ZHU Guixiang ZHANG Shihu FENG Xiao MA Chaoqun ZHANG Yi
中医杂志(英文版)2024,Vol.44Issue(1) :145-155.DOI:10.19852/j.cnki.jtcm.20231110.006

Efficacy of Tounongsan decoction(透脓散方)on pyogenic liver abscess:network pharmacology and clinical trial validation

ZHANG Qi 1CHEN Dexuan 2ZHU Guixiang 3ZHANG Shihu 2FENG Xiao 2MA Chaoqun 2ZHANG Yi2
扫码查看

作者信息

  • 1. Department of General Surgery,Affiliated Hospital of Nanjing University of Chinese Medicine,Jiangsu Province Hospital of Chinese Medicine,Nanjing 210029,China;Zhuzhou Orthopaedic Hospital of Traditional Chinese Medicine,Zhuzhou 412300,China
  • 2. Department of General Surgery,Affiliated Hospital of Nanjing University of Chinese Medicine,Jiangsu Province Hospital of Chinese Medicine,Nanjing 210029,China
  • 3. Department of General Surgery,Jiangsu Province Hospital on Integration of Chinese and Western Medicine,Nanjing 210029,China
  • 折叠

Abstract

OBJECTIVE:To elucidate the molecular mechanisms governing the effect of Tounongsan decoction(透脓散方,TNS)on the pyogenic liver abscess.METHODS:Based on oral bioavailability and drug-likeness,the main active components of TNS were screened using the Traditional Chinese Medicine Systems Pharmacology platform.The GeneCard and UniProt databases were used to establish a database of pyogenic liver abscess targets.The interactive network map of drug-ingredients-target-disease was constructed using Cytoscape software(Version 3.7.2).A protein-protein interaction network was constructed using the STRING database,and the related protein interaction relationships were analyzed.biological process of gene ontology(GO)and Kyoto Encyclopedia of Genes and Genomes(KEGG)enrichment analyses were performed for the core targets.Finally,a clinical trial was performed to verify the reliability of the network pharmacology.RESULTS:Forty active components of TNS decoction were obtained,and 61 potential targets and 11 proteins were identified.Pathways involved in the treatment of pyogenic liver abscess include the phosphatidylinositide 3-kinases-protein kinase B(PI3K-AKT),advanced glycation end products-receptor for advanced glycation end products(AGE-RAGE),and tumor necrosis factor(TNF)signaling pathways.The results of network pharmacology analysis combined with clinical trials validated that TNS decoction could alleviate the inflammatory response of pyogenic liver abscesses by decreasing interleukin 6(IL-6)levels.CONCLUSIONS:TNS decoction has the characteristics of being multi-system,multi-component,and multi-target.Active ingredients in TNS,such as quercetin,kaempferol,fisetin,and β-sitosterol,have strong potential to be candidate drugs for treating pyogenic liver abscesses.The possible mechanism of TSN decoction includes regulating immune and inflammatory responses and reducing IL-6 production to control inflammatory development.

Key words

network pharmacology/clinical trial/liver abscess,pyogenic/Tounongsan decoction

引用本文复制引用

基金项目

Jiangsu Provincial Administration of Traditional Chinese Medicine(YB201814)

Natural Fund of Nanjing University of Chinese Medicine(ZR2021016)

Natural Science Foudation of Jiangsu Province(BE2022819)

出版年

2024
中医杂志(英文版)
中国中医药学会 中国中医研究院

中医杂志(英文版)

影响因子:0.855
ISSN:0255-2922
参考文献量59
段落导航相关论文